Sapiens stock soars after report of Formula in talks to sell control

Published 11/08/2025, 12:36
© Reuters.

Investing.com -- Sapiens International Corporation (NASDAQ:SPNS) stock soared as much as 23% in premarket trading on Monday following a report that its parent company is in advanced talks to sell control of the software firm.

According to Israeli news website Calcalist, Formula Systems is negotiating with U.S. investment funds to sell its controlling stake in Sapiens at a valuation of approximately $2 billion. The report did not provide specific details about the potential buyers or the timeline for completing the transaction.

Sapiens, which provides software solutions for the insurance industry, has seen its shares respond strongly to the news of a possible ownership change. Formula Systems currently maintains a controlling interest in the company.

The reported discussions come amid ongoing consolidation in the enterprise software sector, where private equity firms and strategic investors have been actively pursuing acquisition targets. If completed at the reported valuation, the deal would represent a significant premium to Sapiens’ previous market capitalization.

Neither Sapiens nor Formula Systems has officially confirmed the report at the time of writing.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.